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Abstract Cell iron status was assessed in terms of its capacity 
to mediate cell injury by pro-oxidants. Cultured K562 cells, 
which maintain a stable cytosolic labile iron pool (LIP) of < 0.5 
|xM, underwent distinct changes after short exposures to 
transferrin (Tf) followed by f-butyl hydroperoxide (TBHP) : (a) 
rise in LIP, detectable fluorimetrically; (b) increased lipid 
peroxidation and (c) eventual cell death. All of these effects 
were inhibited by weak bases or iron chelators. Similarly, 
hydrogen peroxide caused rises in both LIP and oxidant species 
detectable with 2',7'-dichlorofluorescin diacetate, which were 
enhanced by preincubation with Tf. The Tf-delivered iron 
disappeared from LIP and the TBHP-reactive pool with a 
t|/2 < 30 min. The results indicate that the catalytic potential of 
iron is highest while in transit between endosomes and cytosolic 
ligands. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Several forms of cell injury induced by pro-oxidant drugs 
involve catalysis by transition metals present in the cell cyto-
sol [1,2]. Iron is the most likely candidate, being the most 
abundant and among the most reactive of those metals. The 
potential for inducing cell damage depends to a large extent 
on factors which affect the availability of particular forms of 
iron needed for conversion of otherwise stable and poorly 
reactive substances (e.g. drugs and metabolites) into highly 
reactive radicals. These include: (a) the chemical forms and 
levels of catalytically active iron, (b) accessibility of those 
forms to the alleged substances and (c) the proximity of the 
biochemical targets to the sites of radical formation. The ma-
jor cell iron-containing compartments comprise (i) ferritin, the 
principal cytoplasmic iron storage protein [3], (ii) mitochon-
dria, the site of synthesis of heme and the primary location of 
heme proteins [4,5], and (iii) the labile pool of cytoplasmic 
iron (LIP), which is associated with low-affinity ligands and 
is accessible to chelators [1,5-7]. Relatively smaller quantities 
of iron are presumably distributed among various organelles, 
some electrostatically bound to numerous negatively charged 
species, including phospholipids and other anionic substances 
[8,9]. Most of these iron fractions can potentially participate 
»Corresponding author. Fax: (972) (2) 6586974. 
E-mail: BILLB@VMS.HUJI.AC.IL 
Abbreviations: BSA, bovine serum albumin; CA, calcein; CA-AM, 
calcein acetoxymethyl ester; DTP A, diethylenetriamine-pentaacetic 
acid; FCS, fetal calf serum; HBS, 150 mM NaCl, 20 mM HEPES, pH 
7.3; LIP, labile iron pool; LPP, lipid peroxidation products; MDA, 
malondialdehyde; PI, propidium iodide; SIH, salicylaldehyde isonico-
tinoyl hydrazone; Tf, transferrin; TBA, thiobarbituric acid; TBHP, 
/-butyl hydroperoxide; DCF, 2',7'-dichlorofluorescein 
in Fenton reactions leading to production of noxious species. 
Even ferritin, in spite of its function as a safe iron(III) repo-
sitory, can release reactive iron(II) upon exposure to reducing 
agents or Superoxide and other radicals [2,11], or participate 
directly in radical mediated protein damage [12]. However, the 
most readily available cell source of reactive iron is apparently 
LIP. This is based primarily on the requirement of partially 
coordinated and weakly bound iron for promoting Fenton 
reactions [1,2] and on the proven capacity of iron chelators 
to prevent cell damage by pro-oxidants [5,6,10] or by ische-
mia/reperfusion [13-15]. LIP constitutes a heterogeneous frac-
tion of iron bound to a variety of ligands [1,5] and entails 
various degrees of catalytic potentials. Using cultured human 
erythroleukemia K562 cells, we show here that resting cell LIP 
levels do not compromise cellular ability to cope with the 
generation of reactive oxygen species by lipophilic pro-oxi-
dants while a fraction of cytosolic iron, which has been newly 
acquired from Tf and is in transit to various cell compart-
ments, has enhanced reactivity toward pro-oxidants, leading 
to cell damage. 
2. Materials and methods 
2.1. Materials 
CA, its acetoxymethyl ester (CA-AM) and 2',7'-dichlorofluorescin 
diacetate were obtained from Molecular Probes (Eugene, OR). The 
divalent metal ionophore A23187, f-butyl hydroperoxide (TBHP), ma-
londialdehyde bisdimethylacetal and thiobarbituric acid (TBA) were 
from Sigma Chem. Co. (St. Louis, MO). All other materials were of 
the highest available grade. The iron chelators, salicylaldehyde isoni-
cotinoyl hydrazone (SIH) (a generous gift from Dr. P. Ponka, Lady 
Davis Institute for Medical Research, Montreal, Canada), 2,2'-bipyr-
idyl (Fluka, Buchs, Switzerland) and DFO (Ciba-Geigy, Basel, Swit-
zerland) were prepared as 50 mM stock solutions in dimethylsulfox-
ide. Chromatographically pure Tf, > 70% iron-saturated, was from 
Kama-Da Industries (Kibbutz Kama, Israel). 
2.2. Cell treatments 
Human erythroleukemia K562 cells in suspension were propagated 
by daily 1:1 dilution in a-MEM medium containing 7% fetal calf 
serum supplemented with L-glutamine and antibiotics. Prior to treat-
ments, the growth medium was removed by centrifugation of the cells. 
Pretreatments with Tf were carried out at a density of 1 X 106 cells/ml 
in bicarbonate-free a-MEM medium containing 20 mM HEPES, pH 
7.3 (aMEM-HEP). Tf was added from a concentrated 25 mg/ml stock 
solution of 150 mM NaCl, 10 mM HEPES-Tris, pH 7.3 (HBS buffer) 
to reach the indicated concentration, and removed after the preincu-
bation, unless otherwise indicated. All treatments with TBHP were 
carried out at 37°C on cells suspended in HBS buffer at 1 X106 
cells/ml. 
2.3. Determination of cellular LIP 
1 ml of cell suspension (1 X106 cells) was loaded with 0.25 itM CA-
AM for 5 min at 37°C in a-MEM-HEP medium containing 2 mg/ml 
BSA. Excess CA-AM was removed by centrifugation and resuspen-
sion in 1 ml of the same medium lacking CA-AM. The cells were 
maintained at room temperature until used, within 60 min. Just prior 
to measurements, 1 ml of the CA loaded cell suspension was centri-
fuged in a microcentrifuge and the cells were resuspended in 2 ml of 
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prewarmed HBS buffer containing 2 niM DTPA. The cell suspension 
was transferred to a stirred, thermostatted (37°C) cuvette and CA 
fluorescence was measured as described previously [16-18]: excitation 
488 nm, emission 517 nm, 10 nm slits, on a Perkin-Elmer LS-5B 
fluorometer equipped with a temperature controlled cuvette holder 
and magnetic stirrer. 
A baseline fluorescent signal was obtained for a suspension of CA-
loaded cells and the signal was adjusted to 60 (on a scale of 0-100). 
The increase in fluorescence produced by the addition of 100 uM of 
the highly permeable iron chelator SIH was recorded. The presence of 
the impermeant chelator DTPA (2 mM) ascertained that the response 
due to SIH was entirely due to its chelation of intracellular CA-bound 
iron. 
Calibrations to determine the relationship between changes in fluo-
rescence and intracellular iron concentration were carried out in HBS 
lacking DTPA but containing an anti-calcein antibody to quench all 
extracellular fluorescence [16,17]. Ionophore A23187 (10 uM) was 
added (this produced < 5 % change in the signal), followed by 1.0 
uM iron(II) added as ferrous ammonium sulfate, and the correspond-
ing change in the fluorescence was determined. This calibration relies 
on the assumption that in the presence of A23187, iron(II) is fully 
equilibrated across the cell membrane, so the CA-detectable concen-
tration of intracellular iron is 1.0 u.M. 
2.4. Lipid peroxidation (LPP) 
LPP was determined by an adaptation of the thiobarbituric acid 
method described by Esterbauer and Cheeseman [20]. Following 
TBHP treatments, the cells ( 2 x l 0 6 per sample) were centrifuged, 
the cell pellet was resuspended in 0.2 ml of cold HBS containing 
2 mM DTPA and 0.01% butylated hydroxytoluene, and 0.5 ml of 
10% TCA was added. After 5 min on ice, the TCA precipitate was 
removed by centrifugation (12000 rpm, 2 min), 0.5 ml of the clear 
supernatant was mixed with an equal volume of 0.67% thiobarbituric 
acid and incubated in a boiling water bath for 10 min. The samples 
were cooled and fluorescence was measured (excitation 522 nm, emis-
sion 550 nm, slits 10 nm, Perkin-Elmer LS-5B fluorometer). Calibra-
tion of LPPs was done with malondialdehyde (MDA) obtained fresh 
by acid hydrolysis of malondialdehyde bisdimethylacetal [20]. Since 
MDA's reaction product with thiobarbituric acid had the same fluo-
rescence spectrum as cell-derived LPPs, we assume that the LPPs were 
mainly cellular malondialdehyde. 
2.5. Determination of intracellular oxidant species with 
2', 7'-dichlorofluorescin diacetate 
Cells were suspended at a density of 0.5 X106 cells/ml in HBS buffer 
containing 10 uM 2',7'-dichlorofluorescin diacetate and incubated for 
15 min at 37°C, with or without H 2 0 2 . The reaction was stopped by 
rapid centrifugation of the cells and resuspension in ice-cold HBS 
buffer containing anti-fluorescein antibody, and the fluorescence of 
the cell suspension was recorded (excitation 488 nm, emission 525 
nm, slits 10 nm, Perkin-Elmer LS-5B fluorometer). The antibody 
was present in excess and quenched all extracellular fluorescence, 
thus ensuring that only intracellular oxidant species-mediated conver-
sion of the non-fluorescent 2',7'-dichlorofluorescin to the fluorescent 
2',7'-dichlorofluorescein was being recorded. The values of intracellu-
lar 2',7'-dichlorofluorescein concentration ([DCF]in) were derived 
from known values of total intracellular volume in each sample (0.5 
|il volume per sample of 0.5 XI06 cells) and calibration of 2',7'-di-
chlorofluorescein concentration vs. fluorescence. 
2.6. Cell viability 
Cell viability was determined by Trypan blue exclusion and by 
uptake of propidium iodide (PI). In the former, cell suspensions 
were mixed with 1/10 volume of 0.4%o Trypan blue and the live/ 
dead ratio was determined by counting in a hemocytometer. The 
second assay is based on the relative impermeability of living cells 
to PI. Following its entry into dead cells, PI intercalates into DNA 
causing a large increase in fluorescence. Samples of 1 ml (1 X106 cells) 
suspended in HBS in 24-well plates were incubated in the presence or 
absence of TBHP for 90 min at 37°C. The cell suspensions were then 
mixed with 1 ml of 5 uM PI in HBS at room temperature, and 
fluorescence at emission 520 nm, excitation 605 nm was measured 
after 2 min, when the signal became stable. Then, 0.1 ml of 10% 
Triton X-100 was added to fully permeabilize all cells in the system 
and give an estimate of the maximal binding of PI. This reading was 
taken as 100% cell death. The percentage of dead cells was calculated 
(after background subtraction) from the ratio of the readings before 
and after Triton X-100 addition. The cultures routinely contained 
2:95%) viable cells, as determined by Trypan blue exclusion. The re-
sults obtained with the PI assay correlated well with those obtained 
with Trypan blue. 
CA has also been used extensively as a vital dye, since it is retained 
only by viable cells and leaks out of non-viable ones. Although we did 
not use CA here as a viability indicator due to its capacity to chelate 
iron, its retention in the cells during the LIP assays was an additional 
indicator of viability. We ascertained that the CA-loaded cells used in 
the LIP assays had an intact permeability barrier, by carrying out the 
assays in the presence of the non-permeable chelator DTPA (2 mM). 
In the experiments shown, this chelator did not cause a gradual de-
quenching of CA which would be indicative of membrane leakiness. 
This was also confirmed by use of an anti-CA fluorescence quenching 
antibody which causes quenching of CA fluorescence in leaky cells. 
3. Results 
3.1. Effect of TBHP and H202 on cellular LIP, MDA 
production and viability 
Previously we have shown that K562 cells exposed to 
T B H P and H2O2 show an increase in LIP as detectable with 
1.0-
o 
it 
0) 
0) 
> o 
0.0 
1.0-
o 
<D 
> 
CD 
DC 
0.0 
0.0 0.5 
TBHP (mM) 
1.0 
tf^Jr 
0.0 0.5 1.0 
Fig. 1. Effect of TBHP and H 2 0 2 on cellular LIP, MDA production 
and viability. K562 cells were preincubated for 20 min at 37°C in 
serum-free medium in the presence (filled symbols) and absence 
(empty symbols) of 100 ug/ml Tf. After removal of the Tf by centri-
fugation, the cells were treated with various concentrations of 
TBHP (A) or H 2 0 2 (B) in HBS solution for 15 min at 37°C. The 
reaction was stopped by centrifugation of the cells and resuspension 
in a-MEM-HEP medium containing 2 mg/ml BSA. LIP levels (tri-
angles) were determined after loading cells with 0.25 uM CA-AM 
for 5 min at 37°C, as described in Section 2. Cellular MDA levels 
(circles) were determined immediately after the treatments. For 
measurements of cell death (CD, squares), cells were suspended in 
HBS solution with and without 100 ug/ml Tf, and incubated for 90 
min at 37°C in the presence of either TBHP or H 2 0 2 . Cell viability 
was determined using the PI method as described in Section 2. Data 
are given as relative to the maximal value attained in all the experi-
ments (set as 1.0). The value of 1.0 corresponds to: 2 uJVI for LIP, 
5 pmol/106 cells for MDA and 40% cell death for CD. 
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min, their basal LIP rose by 2.3-fold (from 0.35 to 0.80 uM, 
Fig. 1). A subsequent 15 min exposure to TBHP or H 2 0 2 
caused a further 2.5- and 1.9-fold increase in LIP, respectively. 
The TBHP-generated production of MDA followed the same 
pattern as LIP (Fig. 1A). Increasing concentrations of TBHP 
caused a gradual rise in cellular MDA from a basal level of 
Fig. 2. The effect of blockade of Tf-iron release on TBHP-mediated 
LIP increase, MDA production and cell viability. K562 cells were 
preincubated for 20 min at 37°C in serum-free medium in the pres-
ence and absence of 100 ug/ml Tf, with and without 25 mM ammo-
nium chloride (AC). After removal of the Tf by centrifugation, the 
cells were treated with 0.25 mM TBHP, with or without AC as indi-
cated, for 15 min at 37°C. The reaction was stopped by centrifuga-
tion of the cells and resuspension in a-MEM-HEP medium contain-
ing 2 mg/ml BSA. The cells were then analyzed for LIP levels (A) 
and for MDA production, in pmol MDA/106 cells (B), as described. 
C: Cells taken from culture were centrifuged and resuspended in 
HBS solution with the indicated additions. Cell viability was deter-
mined after 90 min at 37°C, as described. Empty bars: no Tf; 
hatched bars: 100 ug/ml Tf; Con: control; AC: 25 mM ammonium 
chloride; TBHP: 0.25 mM TBHP. 
CA [18]. Accordingly, the LIP of cells incubated for 15 min 
with increasing concentrations of pro-oxidants rose from a 
basal level of 0.35 uM to maximally 3.6-fold with 1 mM 
TBHP (Fig. 1A) and 2.15-fold with 1 mM H 2 0 2 (Fig. IB). 
When the cells were preincubated with Tf (0.1 mg/ml) for 20 
Fig. 3. Effect of iron chelators on H 2 0 2 - and TBHP-mediated LIP 
increase, MDA production and cell viability. K562 cells were prein-
cubated for 20 min at 37°C in a-MEM-HEP medium containing 
100 ug/ml Tf. After removal of the Tf by centrifugation, the cells 
were resuspended in HBS solution containing 0.1 mM BIP (empty 
bars), 0.1 mM DFO (hatched bars) or no chelator (cross-hatched 
bars). They were then treated with 1.0 mM H2O2 or 0.25 mM 
TBHP for 15 min at 37°C. The reaction was stopped by centrifuga-
tion of the cells and resuspension in a-MEM-HEP medium contain-
ing 2 mg/ml BSA. The cells were then analyzed for LIP levels (A) 
and for MDA production in pmol MDA/106 cells (B), as described. 
C: Cells taken from culture were centrifuged and resuspended in 
HBS solution contaming 100 |xg/ml Tf with the indicated additions. 
Cell viability was determined after 90 min at 37°C, as described. 
Cross-hatched bars: no chelator; empty bars: 0.1 mM BIP; hatched 
bars: 0.1 mM DFO; Con: untreated control; H 2 0 2 : 1.0 mM 
H 2 0 2 ; TBHP: 0.25 mM TBHP. 
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0.65 pmol/106 cells in controls lacking Tf up to 4 pmol/106 
cells (i.e. 6-fold) at 1 mM TBHP. After a 20 min preincuba-
tion with Tf, the MDA production in response to TBHP was 
augmented by 1-1.5 pmol MDA/106 cells (Fig. 1A). In con-
trast to TBHP, H 2 0 2 failed to cause any detectable MDA 
formation (Fig. IB). 
The 15 min exposure of cells with basal LIP levels to either 
TBHP or H2O2 caused no detectable change in the cell per-
meability barrier, as measured by accumulation of either Try-
pan blue or PI, or by leakage of calcein from CA-AM-loaded 
cells (data not shown). However, a significant level of cell 
death became detectable after >45 min incubations with 
TBHP. As shown in Fig. 1A, a 90 min exposure of cells to 
TBHP in the absence of Tf caused only <16% cell death, 
while in the presence of Tf it rose to 41%. H 2 0 2 , at concen-
trations up to 1 mM (and even 5 mM, not shown), caused no 
detectable toxicity within 90 min, with or without Tf (Fig. 
IB). 
3.2. The effect of blockade of Tf-iron delivery on 
TBHP-mediated LIP increase, MDA production and 
cell viability 
In order to show that the TBHP-mediated increases in LIP, 
MDA production and cell death required the prior release of 
iron from Tf, we tested the effect of the weak base NH4C1, 
which is known to alkalinize endosomes and inhibit the re-
lease of iron from Tf [17]. As shown in Fig. 2, NH4C1 (25 
mM) prevented the Tf-mediated increase in LIP, both in the 
presence and in the absence of TBHP, but had no effect on 
the basal LIP, i.e. in cells not preincubated with Tf (Fig. 2A). 
A similar pattern of inhibitory effects of NH4C1 was obtained 
for MDA production (Fig. 2B) and cell death (Fig. 2C). In 
both cases, NH4CI did not affect MDA production and cell 
death due to TBHP in the absence of Tf, but prevented their 
augmentation by Tf. Chloroquine (0.2 mM), another weak 
base which also alkalinizes acidic compartments, blocked the 
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Fig. 4. Generation of intracellular oxidant species by exogenous 
H2O2 as determined with 2',7'-dichlorofluorescin diacetate. K562 
cells were preincubated for 20 min at 37°C in a-MEM-HEP me-
dium in the presence (filled symbols) and absence (empty symbols) 
of 100 ug/ml Tf. After removal of the Tf by centrifugation, the cells 
were resuspended in HBS solution containing 10 uM 2',7'-dichloro-
fluorescin diacetate. They were then incubated at 37°C in the pres-
ence (squares) and absence (circles) of 50 uM H2O2 for the times 
indicated, and the fluorescence of intracellular 2',7'-dichlorofluores-
cein ([DCF]in) was determined as described in Section 2. 
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Fig. 5. Removal of newly acquired iron from the TBHP-reactive 
pool. K562 cells were preincubated in a-MEM-HEP medium con-
taining 100 ug/ml Tf for 10 min at 37°C, Tf was removed by centri-
fugation and the cells were further incubated at 37°C in a-MEM-
HEP medium for periods of 1-50 min, as shown. They were then 
treated with 0.25 mM TBHP for 15 min and immediately assayed 
for (A) LIP and (B) MDA production (expressed as pmol MDA/ 
106 cells). C: The cells were first preincubated at 37°C in serum-free 
culture medium containing 100 ug/ml Tf for 2 h, Tf was then re-
moved by centrifugation, the cells were further incubated at 37°C in 
culture medium for the times indicated, and then treated with 0.25 
mM TBHP in HBS for 90 min prior to viability determinations. 
Dashed lines indicate the levels observed for control cells treated 
with TBHP without pre-exposure to Tf. 
action of Tf similarly to NH4CI, although it was only 35% as 
potent (not shown). 
The inhibitory effect of NH4C1 indicates that in order for 
the iron to be TBHP-reactive, it must first be released from 
Tf, presumably in the acidic environment of the endosome. 
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We showed that neither TBHP nor H2O2 release iron from Tf 
directly, by incubating Tf with the reagents in solution and 
measuring the release of iron with the fluorescent iron probe 
methylanthranilic desferrioxamine [17]. Using this method, 
iron was found to be spontaneously released from Tf at 
pH < 6.0 but not at pH > 6.0, and this was not affected by 
0.5 mM TBHP or H202 (data not shown). 
3.3. Effect of iron chelators on TBHP-mediated LIP increase, 
MDA production and cell viability 
The iron chelators 2,2'-bipyridyl (BIP) and desferrioxamine 
(DFO), both at 0.1 mM, were tested for their capacity to 
decrease LIP levels and concomitantly prevent TBHP-medi-
ated damage to cells which had been preincubated with Tf 
(Fig. 3). These chelators decreased the LIP levels by 19 and 
35% respectively in untreated controls, and virtually abro-
gated the increase in LIP due to both H2O2 and TBHP 
(Fig. 3A). TBHP-mediated MDA production was inhibited 
by 88 and 58% by BIP and DFO respectively (Fig. 3B). These 
chelators also inhibited TBHP-mediated cell death by 96 and 
71% (Fig. 3C). Whereas DFO is considerably less hydropho-
bic than BIP and enters cells more slowly, it apparently 
reached sufficient intracellular levels during the 15 min prein-
cubation to chelate a portion of the LIP. Moreover, DFO's 
relatively poor permeability may explain its lower inhibitory 
activity towards TBHP-mediated MDA production and cell 
death. Two other permeable iron chelators, o-phenanthroline 
and SIH, at 0.1 mM, had similar inhibitory effects to those of 
BIP on both MDA production and cell death (data not 
shown). 
3.4. Generation of intracellular oxidant species by 
exogenous H2O2, as determined with 
2', 7'-dichlorofluorescin diacetate 
Since H2O2 failed to cause detectable MDA production or 
significant cell death, we sought an alternative method for 
detecting H202-derived cytosolic oxidant species. The probe 
of choice was 2',7'-dichlorofluorescin diacetate, which enters 
cells readily, is hydrolyzed by esterases to the non-fluorescent 
2',7'-dichlorofluorescin and undergoes conversion to the fluo-
rescent 2',7'-dichlorofluorescein (DCF) upon reaction with 
oxidant species. The reaction of 2',7'-dichlorofluorescin with 
H2O2 alone is relatively slow, but is markedly enhanced in the 
presence of iron [31]. As shown in Fig. 4, untreated control 
cells showed a slow accumulation of DCF, indicative of the 
basal level of endogenous oxidant species. Exogenous H2O2 
(50 uM) raised the DCF levels by 3.1-fold. Pretreatment with 
Tf increased DCF accumulation in control and H202-treated 
cells by 10 and 22% respectively. Although higher concentra-
tions of exogenous H2O2 produced parallel increases in DCF 
accumulation, the relative increase due to Tf preincubation 
was most marked at concentrations below 50 uM H2O2 (not 
shown). 
3.5. Removal of newly acquired iron from the TBHP-reactive 
pool 
As demonstrated in Figs. 1 and 2, newly acquired Tf-iron 
shows an enhanced reactivity with TBHP. Therefore it was of 
interest to determine how rapidly the cells can shift this iron 
to a less reactive form, and whether this is reflected in parallel 
changes in LIP levels. The initial rise in LIP, generated in cells 
by TBHP after a 10 min preincubation with 100 ng/ml Tf, was 
followed by a time-dependent decline after removal of Tf (Fig. 
5A). The half-life, ti/2, of the decay toward the level of cells 
that had not been preincubated with Tf was 21 min. A similar 
pattern was obtained for MDA production, where the decay 
ti/2 was 16 min (Fig. 5B). The minimum preincubation period 
with Tf for a detectable increase in TBHP-mediated cell death 
was approx. 30 min. Therefore we chose an optimal Tf pre-
incubation period of 2 h for cell death determinations. Under 
this condition, the ti/2 of the period required for the cells to 
become as resistant to TBHP as control cells that had not 
been preincubated with Tf was 27 min (Fig. 5C). 
4. Discussion 
4.1. The relationship between LIP levels and oxidant injury 
The view that a cytosolic form of iron confers on cells 
susceptibility to pro-oxidant-mediated damage [1,2,14] is 
based on two major pieces of evidence: (i) the increased sus-
ceptibility to oxidant stress artificially created by prolonged 
exposures to iron salts [5] and (ii) the protective action con-
ferred by various iron chelators on oxidatively stressed cells 
and tissues [1,2,5,6,21]. While strongly suggestive, neither of 
these experimental approaches addresses the question of 
whether iron acquired by normal physiological pathways 
can be a catalyst of oxidant-mediated injury. On the one 
hand, the uncontrolled iron overload generated by exposure 
to non-Tf-bound iron can result in extremely high intracellu-
lar iron concentrations, vastly in excess of the cytoplasmic 
chelating or buffering capacity. On the other hand, full pro-
tection by iron chelators implies that only the chelatable or 
labile cellular iron (LIP) is potentially reactive and germane to 
the oxidant damage. 
We set out to assess whether the physiological forms of iron 
delivered to cells are chemically reactive when challenged with 
pro-oxidants. We used Tf, the in vivo iron carrier, as an iron 
source, since, in contrast to the facilitated transport of inor-
ganic iron [22,23], endocytic uptake of iron via the Tf recep-
tor-Tf system is relatively slow, highly regulated and furnishes 
the physiological forms of iron. The levels of the labile or 
chelatable forms of cytosolic iron were monitored on line as 
LIP levels with the fluorescent intracellular iron probe, calcein 
[17-19], and correlated with pro-oxidant-mediated cell dam-
age. A distinct correlation was found between LIP levels and 
the extent of cellular injury in cells treated with TBHP: (i) 
when the initial LIP was increased by preincubation with Tf, 
MDA production rose in parallel, and (ii) the chelators BIP 
(specific for iron(II)) and DFO (binds both iron(II) and (III)) 
lowered LIP levels and concomitantly decreased MDA pro-
duction. Similarly, the capacity of TBHP to cause cell death 
was found to be determined by iron supply. K562 cells taken 
from cultures grown in 7% fetal calf serum were resistant to 
TBHP for up to 45 min, however they underwent a break-
down in the permeability barrier when exposed to TBHP for 
90 min in the presence of Tf as an iron source. The actual LIP 
levels attained in the damaged cells after 90 min of incubation 
with TBHP in the presence of Tf could not be experimentally 
determined. We can only surmise that they might be at least 
as high as those found after short, 15 min incubations shown 
in Figs. 1-3, i.e. >2.0 uM. 
4.2. Differential sensitivity of K562 cells to H2O2 and TBHP 
In contrast to TBHP, H2O2 failed to cause any cell damage 
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detectable by the present assays. This was in spite of the fact 
that H 2 0 2 caused a significant increase in the levels of oxidant 
species in the cytosol, as shown by the enhanced accumulation 
of the fluorescent probe DCF (Fig. 4). Furthermore it caused 
the release of a significant portion of non-chelatable iron into 
the LIP, detected as a rise in LIP levels in the absence of an 
external iron source. This indicates that the H2O2 was indeed 
cell-active but either did not have sufficient access to iron 
targets or did not accumulate to sufficient levels to generate 
lipid peroxidation products. While several possible mecha-
nisms could explain the quantitative differences between the 
effects of the two pro-oxidants, we favor the possibility that 
iron adsorbed to membranes might react with the hydropho-
bic TBHP, which partitions into lipids and accumulates in cell 
membranes. These two reactants, when co-localized in mem-
branes, might induce localized damage, principally lipid per-
oxidation. In contrast, the freely soluble H2O2 becomes uni-
formly dispersed throughout the cell, giving rise to a variety of 
oxidation products [1,2,20] of which only a small fraction 
would be MDA arising from lipid peroxidation. 
of this iron(II) to high affinity ligands (such as ferritin), con-
comitant with oxidation to iron(III). The inactivation kinetics 
are in reasonable agreement with our previous determination 
of the transit time of Tf-55Fe from the chelatable iron pool to 
a chelator-inaccessible fraction in K562 cells, as 1-2 h [17]. 
In summary, our results indicate that cellular LIP is in 
dynamic association with non-LIP forms of iron which are 
potentially reactive. Thus the iron supplied by Tf endocytosis 
carries high catalytic potential during its transit between endo-
somes and high-affinity inactivating ligands. The physiological 
relevance of these findings would depend on the rate of Tf-
iron acquisition, i.e. cellular Tf-receptor levels, as well as the 
concentration and type of pro-oxidant species accumulated by 
the cells. 
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4.3. Unmasking of weakly bound cytoplasmic iron by its 
reactivity with pro-oxidants 
The observation that H2O2 and TBHP can release cellular 
iron from a non-LIP, chelator-inaccessible fraction into cyto-
solic LIP detectable with calcein ([18], and present data), is 
compatible with the idea that LIP is in dynamic equilibrium 
with other fraction(s) of weakly bound iron. Previously we 
have shown that calcein-detectable LIP is composed primarily 
of iron(II) and about 20% iron(III). Presumably, much of the 
cytoplasmic iron(III), being tightly bound to various ligands, 
would not be detected as LIP in this assay. One well defined 
fraction of iron(III) is bound to ferritin, but it can be dis-
lodged as iron(II) by reducing species [11,24,25]. Other ligands 
for iron(III) may include nucleotides [4,16] or polypeptides 
[7,27]. Irrespective of the specific iron-binding moieties, the 
observed peroxide-mediated increase in LIP levels is explain-
able by an initial Fenton reaction between the peroxide and 
iron(II), giving rise to free radicals which then reduce tightly 
bound iron(III) and release it as the highly soluble iron(II) 
ion. The free iron(II) is then detected by calcein, whose reac-
tivity with iron(II) is greater than with iron(III) [28]. This 
mechanism is in line with observations of release of tissue 
iron following hypoxia/reperfusion [14,15,26] and oxidant 
stress [29]. 
4.4. Inactivation of newly acquired iron 
The principal element of the present studies is the distinc-
tion, by means of TBHP reactivity, between newly acquired 
iron and that which has already been 'processed' in the cyto-
plasm. This is illustrated in Fig. 5, where newly acquired Tf-
iron initially reacts with TBHP (in terms of increases in LIP, 
MDA production and cell death), but its reactivity is gradu-
ally lost with time and virtually disappears after about 60 min. 
Conceivably, immediately after its exit from the endosome, 
the newly released iron(II) [17,30] is still closely associated 
with internal membrane surfaces where it can easily react 
with TBHP partitioned within the lipid bilayer. This physical 
proximity between pro-oxidant and metal catalyst would also 
explain the differences between H2O2 and TBHP in causing 
lipid peroxidation and cell death. The subsequent decrease in 
LIP and in TBHP-mediated damage likely reflects the binding 
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